Bakker GH - Search Results

1

Growth factor-receptor pathway interfering treatment by somatostatin analogs and suramin: preclinical and clinical studies.

Klijn JG, Setyono-Han B, Bakker GH, van der Burg ME, Bontenbal M, Peters HA, Sieuwerts AM, Berns PM, Foekens JA. Klijn JG, et al. Among authors: bakker gh. J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):1089-95. doi: 10.1016/0960-0760(90)90471-v. J Steroid Biochem Mol Biol. 1990. PMID: 1981013 Review.

2

Treatment of breast cancer with different antiprogestins: preclinical and clinical studies.

Bakker GH, Setyono-Han B, Portengen H, De Jong FH, Foekens JA, Klijn JG. Bakker GH, et al. J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):789-94. doi: 10.1016/0960-0760(90)90421-g. J Steroid Biochem Mol Biol. 1990. PMID: 2285592

3

Endocrine and antitumor effects of combined treatment with an antiprogestin and antiestrogen or luteinizing hormone-releasing hormone agonist in female rats bearing mammary tumors.

Bakker GH, Setyono-Han B, Portengen H, De Jong FH, Foekens JA, Klijn JG. Bakker GH, et al. Endocrinology. 1989 Sep;125(3):1593-8. doi: 10.1210/endo-125-3-1593. Endocrinology. 1989. PMID: 2527151

4

The somatostatin analog Sandostatin (SMS201-995) in treatment of DMBA-induced rat mammary tumors.

Bakker GH, Setyono-Han B, Foekens JA, Portengen H, van Putten WL, de Jong FH, Lamberts SW, Reubi JC, Klijn JG. Bakker GH, et al. Breast Cancer Res Treat. 1990 Nov;17(1):23-32. doi: 10.1007/BF01812681. Breast Cancer Res Treat. 1990. PMID: 1965705

5

Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.

Bakker GH, Setyono-Han B, Henkelman MS, de Jong FH, Lamberts SW, van der Schoot P, Klijn JG. Bakker GH, et al. Cancer Treat Rep. 1987 Nov;71(11):1021-7. Cancer Treat Rep. 1987. PMID: 3119199

6

Antiprogestins, a new form of endocrine therapy for human breast cancer.

Klijn JG, de Jong FH, Bakker GH, Lamberts SW, Rodenburg CJ, Alexieva-Figusch J. Klijn JG, et al. Among authors: bakker gh. Cancer Res. 1989 Jun 1;49(11):2851-6. Cancer Res. 1989. PMID: 2720645

7

Effects of sandostatin and castration on pancreatic carcinogenesis in rats and hamsters.

Meijers M, Woutersen RA, van Garderen-Hoetmer A, Bakker GH, de Jong FH, Foekens JA, Klijn JG. Meijers M, et al. Among authors: bakker gh. Int J Cancer. 1992 Jan 21;50(2):246-51. doi: 10.1002/ijc.2910500214. Int J Cancer. 1992. PMID: 1730518

8

Effects of castration, alone and in combination with aminoglutethimide, on growth of (pre)neoplastic lesions in exocrine pancreas of rats and hamsters.

Meijers M, Woutersen RA, van Garderen-Hoetmer A, Bakker GH, de Jong FH, Foekens JA, Klijn JG. Meijers M, et al. Among authors: bakker gh. Carcinogenesis. 1991 Sep;12(9):1707-13. doi: 10.1093/carcin/12.9.1707. Carcinogenesis. 1991. PMID: 1832592

9

Effects of the progesterone antagonist RU486 on ovarian activity in the rat.

van der Schoot P, Bakker GH, Klijn JG. van der Schoot P, et al. Among authors: bakker gh. Endocrinology. 1987 Oct;121(4):1375-82. doi: 10.1210/endo-121-4-1375. Endocrinology. 1987. PMID: 3653032

10

Lutropin stimulates de novo synthesis of short-lived proteins required for lutropin-dependent steroid production in tumour Leydig cells.

Bakker GH, Hoogerbrugge JW, Rommerts FF, van der Molen HJ. Bakker GH, et al. J Steroid Biochem. 1985 Mar;22(3):311-4. doi: 10.1016/0022-4731(85)90431-5. J Steroid Biochem. 1985. PMID: 2581067

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters